Glaxo appoints new chief executive

One of the world’s largest pharmaceutical firms GlaxoSmithKline today announced a replacement for chief executive Jean-Paul Garnier.

One of the world’s largest pharmaceutical firms GlaxoSmithKline today announced a replacement for chief executive Jean-Paul Garnier.

Andrew Witty, 43, currently president for Glaxo’s European pharmaceuticals arm, will succeed Mr Garnier when he retires at the end of May.

You have reached your article limit. Already a subscriber? Sign in

185 years of the Irish Examiner

185th
Anniversary Offer

Six months of digital access for €18.50

No obligation. Ts&Cs apply.

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited